John L. Knopf, CEO and President at ACCELERON PHARMA INC (XLRN), sold 17,500 shares at $29.78 ($521K) on 2014-08-14, disclosed to the SEC on 2014-08-15.
Scheduled sale ($521k) by CEO and President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.78 | 7,500 | $223K | 42.9% |
| 2 | $29.78 | 10,000 | $298K | 57.1% |
| Total | $29.78 avg | 17,500 | $521K | 100% |
| Filing → |
| XLRN | SELL | 2016-05-20 | $3.3M | — | Filing → |
| XLRN | SELL | 2015-10-09 | $463K | — | Filing → |
| XLRN | SELL | 2015-09-10 | $574K | — | Filing → |